Additionally, the mutations of other genes, such as apolipoprotein E (ApoE), bridging integrator1 (BIN1), and cluster protein (CLU), affect the clearance rate of Aβ and increase the accumulation of Aβ, especially in late-onset AD, which possesses a risk of AD [86]. The gene discussed is APOE; the disease is Alzheimer disease.